- $4.44bn
- $7.77bn
- $4.66bn
- 71
- 63
- 58
- 69
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,870 | 4,088 | 4,139 | 4,452 | 4,656 |
Cost of Revenue | |||||
Gross Profit | 1,434 | 1,495 | 1,416 | 1,455 | 1,680 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,695 | 3,843 | 3,728 | 4,382 | 4,501 |
Operating Profit | 175 | 245 | 410 | 70 | 155 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 148 | 5.9 | 259 | -139 | -8.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 159 | 44.2 | -131 | -131 | -4.4 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 146 | -163 | -68.9 | -141 | -12.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 146 | -163 | -68.9 | -141 | -12.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.43 | 0.457 | 0.143 | -0.509 | 0.587 |
Dividends per Share |